Quantification and discriminative power of F-18-FE-PE2I PET in patients with Parkinson's disease

Rationale Dopamine transporter (DAT) imaging is an important adjunct in the diagnostic workup of patients with Parkinsonism. F-18-FE-PE2I is a suitable PET radioligand for DAT quantification and imaging with good pharmacokinetics. The aim of this study was to determine a clinical optimal simplified reference tissue-based image acquisition protocol and to compare the discriminatory value and effect size for F-18-FE-PE2I to that for I-123-FP-CIT scan currently used in clinical practice. Methods Nine patients with early Parkinson's disease (PD, 64.3 +/- 6.8 years, 3M), who had previously undergone a I-123-FP-CIT scan as part of their diagnostic workup, and 34 healthy volunteers (HV, 47.7 +/- 16.8 years, 13M) underwent a 60-min dynamic F-18-FE-PE2I PET-MR scan on a GE Signa 3T PET-MR. Based on dynamic data and MR-based VOI delineation, BPND, semi-quantitative uptake ratio and SUVR[t1-t2] images were calculated using either occipital cortex or cerebellum as reference region. For start-and-end time of the SUVR interval, three time frames [t(1)-t(2)] were investigated: [15-40] min, [40-60] min, and [50-60] min postinjection. Data for putamen (PUT) and caudate nucleus-putamen ratio (CPR) were compared in terms of quantification bias versus BPND and discriminative power. Results Using occipital cortex as reference region resulted in smaller bias of SUVR with respect to BPND + 1 and higher correlation between SUVR and BPND + 1 compared with using cerebellum, irrespective of SUVR [t(1)-t(2)] interval. Smallest bias was observed with the [15-40]-min time window, in accordance with previous literature. The correlation between BPND + 1 and SUVR was slightly better for the late time windows. Discriminant analysis between PD and HV using both PUT and CPR SUVRs showed an accuracy of >= 90%, for both reference regions and all studied time windows. Semi-quantitative I-123-FP-CIT and F-18-FE-PE2I values and relative decrease in the striatum for patients were highly correlated, with a higher effect size for F-18-FE-PE2I for PUT and CPR SUVR. Conclusion F-18-FE-PE2I is a suitable radioligand for in vivo DAT imaging with high discriminative power between early PD and healthy controls. Whereas a [15-40]-min window has lowest bias with respect to BPND, a [50-60]-min time window at pseudoequilibrium can be advocated in terms of clinical feasibility with optimal discriminative power. The occipital cortex may be slightly preferable as reference region because of the higher time stabi